NYSE:APR

Apria (APR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$37.50
$37.50
50-Day Range
$37.26
$37.50
52-Week Range
$22.36
$40.00
Volume
N/A
Average Volume
682,285 shs
Market Capitalization
$1.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
APR stock logo

About Apria Stock (NYSE:APR)

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.

APR Stock News Headlines

Q1 2024 Owens & Minor Inc Earnings Call
Urgent Alert: Is the U.S. Implementing a Digital Dollar?
Our exclusive guide, "Exploring the Future of the U.S. Dollar in a Digital World," is your essential resource in navigating this uncertain terrain. Inside, you'll find expert insights, strategies, and actionable steps to shield your wealth from the impending digital dollar storm.
Urgent Alert: Is the U.S. Implementing a Digital Dollar?
Our exclusive guide, "Exploring the Future of the U.S. Dollar in a Digital World," is your essential resource in navigating this uncertain terrain. Inside, you'll find expert insights, strategies, and actionable steps to shield your wealth from the impending digital dollar storm.
Medical Equipment Rental Global Market Report 2023
Apria Notice of Data Breach
Q1 2023 Owens & Minor Inc Earnings Call
Here’s Why Owens & Minor (OMI) is Declining
See More Headlines
Receive APR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apria and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home Health Care Services
Sub-Industry
N/A
Fax
N/A
Employees
6,080
Year Founded
N/A

Profitability

Net Income
$64.88 million
Pretax Margin
7.84%

Debt

Sales & Book Value

Annual Sales
$1.15 billion
Cash Flow
$5.27 per share
Book Value
$1.12 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.34 billion
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

APR Stock Analysis - Frequently Asked Questions

How were Apria's earnings last quarter?

Apria, Inc. (NYSE:APR) released its quarterly earnings results on Thursday, November, 4th. The company reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. The business had revenue of $287.20 million for the quarter, compared to the consensus estimate of $286 million. Apria had a net margin of 5.66% and a trailing twelve-month return on equity of 586.18%.

When did Apria IPO?

Apria (APR) raised $150 million in an IPO on Thursday, February 11th 2021. The company issued 7,500,000 shares at a price of $19.00-$21.00 per share. Citigroup and Goldman Sachs & Co. LLC BofA Securities J.P. Morgan UBS Investment Bank served as the underwriters for the IPO and Piper Sandler Citizens Capital Markets Fifth Third Securities TD Securities Academy Securities Blaylock Van, LLC Penserra Securities LLC Stern was co-manager.

This page (NYSE:APR) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners